Padmaja Kaul, University of Toronto

Research

30-Day Readmission Administrative Health Data Congenital Heart Disease In Adults Pan-Canadian Transcatheter Interventions

Latest funding

BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
CIHR · 2025 · Co-investigator
$1,268,322
Using Administrative Health Data to Understand Readmissions after Early Discharge following Transcatheter Congenital Heart Disease Interventions in Canada
CIHR · 2023 · Principal investigator
$382,500
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
CIHR · 2023 · Co-investigator
$100,000

All 4 grants and awards

BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)

Co-investigatorCIHR2025Project Grant

Principal investigators: Grandi, Sonia; Longo, Cristina M

Keywords: Biologics; Child Outcomes; Drug Effectiveness; Drug Safety; Infant Outcomes; Maternal Health; Pharmacoepidemiology; Population-Based Data; Pregnancy

$1,268,322

Using Administrative Health Data to Understand Readmissions after Early Discharge following Transcatheter Congenital Heart Disease Interventions in Canada

Principal investigatorCIHR2023Project Grant

Principal investigators: Abrahamyan, Lusine; Horlick, Eric; Kaul, Padmaja R

Keywords: 30-Day Readmission; Administrative Health Data; Congenital Heart Disease In Adults; Pan-Canadian; Transcatheter Interventions

$382,500

BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)

Co-investigatorCIHR2023Pro. Gr.- PA: Human Development Child and Youth Health - Early Career Support

Principal investigators: Grandi, Sonia; Longo, Cristina M

Keywords: Biologics; Child Outcomes; Drug Effectiveness; Drug Safety; Infant Outcomes; Maternal Health; Pharmacoepidemiology; Population-Based Data; Pregnancy

$100,000

Improving Canadian Outcomes Research On the Novel SARS-CoV-2 using Analytics: the CORONA Consortium

Co-investigatorCIHR2020Op Gr: COVID-19 Rapid Research FO - Clinical Mgmt/Health System Interventions

Principal investigators: Lee, Douglas S; Mcalister, Finlay A

Keywords: Cardiovascular Disease; Health Services Research; Machine Learning; Medication Adherence; Observational Research; Outcomes Research; Risk Factors; Risk Prediction; Sars-Cov-2

$409,179

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: 30-Day Readmission Dear Professor Kaul, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on 30-day readmission connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Using Administrative Health Data to Understand Readmissions after Early Discharge following Transcatheter Congenital Heart Disease Interventions in Canada" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]